Synthesis, biological evaluation and molecular modeling studies of Schiff bases derived from 4-methylsalicylic acid as potential immunosuppressive agents
Tóm tắt
A series of Schiff bases derived from 4-methylsalicylic acid (4a–4s) were synthesized, 14 of which (4a–4h, 4j–4l, 4n, 4q, and 4s) were reported for the first time. All the synthesized compounds were evaluated for their immunosuppressive activities for the first time. Among them, compound 4o displayed the most potent biological activity against lymph node cells (IC50 = 1.02 μM for lymph node cells and IC50 = 2.17 μM for PI3Kγ). The results of apoptosis and western-blot assays demonstrated that the immunosuppressive activity of compound 4o might be mediated by the inhibition of PI3K/AKT signaling pathway. Docking simulation was performed to position compound 4o into the PI3Kγ structure active site to determine the probable binding model.
Tài liệu tham khảo
Bekhit AA, Hesham TY, Sherif AF, Baraka AM (2003) Design and synthesis of some substituted 1H-pyrazolyl-thiazolo[4,5-d]pyrimidines as anti-inflammatory–antimicrobial agents. Eur J Med Chem 38:27–36
Camps M, Rückle T, Ji H, Ardissone V, Rintelen F, Shaw J, Ferrandi C, Chabert C, Gillieron C, Françon B, Martin T, Gretener D, Perrin D, Leroy D, Vitte PA, Hirsch E, Wymann MP, Cirillo R, Schwarz MK, Rommel C (2005) Blockade of PI3K gamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat Med 11:936–943
Cantley LC (2002) The phosphoinositide 3-kinase pathway. Science 296:1655–1657
Chavan SP, Sivappa R (2004) Total synthesis of nothapodytine B and (±)-mappicine. Tetrahedron Lett 45:3941–3943
Deane JA, Fruman DA (2004) Phosphoinositide 3-kinase diverse roles in immune cell activation. Annu Rev Immunol 22:563–598
Demirbas N, Karaoglu SA, Demirbas A, Sancak K (2004) Synthesis and antimicrobial activities of some new 1-(5-phenylamino-[1,3,4]thiadiazol-2-yl) methyl-5-oxo-[1,2,4]triazole and 1-(4-phenyl-5-thioxo-[1,2,4]triazol-3-yl)methyl-5-oxo-{1,2,4] triazole derivatives. Eur J Med Chem 39:793–804
Ferrandi C, Ardissone V, Ferro P, Rückle T, Zaratin P, Ammannati E, Hauben E, Rommel C, Cirillo R (2007) Phosphoinositide 3-kinase γ inhibition plays a crucial role in early steps of inflammation by blocking neutrophil recruitment. J Pharmacol Exp Ther 322:923–930
Foster FM, Traer CJ, Abraham SM, Fry MJ (2003) The phosphoinositide (PI) 3-kinase family. J Cell Sci 116:3037–3040
Fougerat A, Gayral S, Gourdy P, Schambourg A, Rückle T, Schwarz MK, Rommel C, Hirsch E, Arnal JF, Salles JP, Perret B, Breton-Douillon M, Wymann MP, Laffargue M (2008) Genetic and pharmacological targeting of phosphoinositide 3-kinase-γ reduces atherosclerosis and favors plaque stability by modulating inflammatory processes. Circulation 117:1310–1317
Giannini EG, Kane SV, Testa R, Savarino V (2005) 5-ASA and colorectal cancer chemoprevention in inflammatory bowel disease: can we afford to wait for ‘best evidence’? Dig Liver Dis 37:723–731
Hackstein H, Thomson AW (2004) Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat Rev Immunol 4:24–34
Kahan BD (2003) Individuality: the barrier to optimal immunosuppression. Nat Rev Immunol 3:831–912
Knight SD, Adams ND, Burgess JL, Chaudhari AM, Darcy MG, Donatelli CA, Luengo JI, Newlander KA, Parrish CA, Ridgers LH, Sarpong MA, Schmidt SJ, Van Aller GS, Carson JD, Diamond MA, Elkins PA, Gardiner CM, Garver E, Gilbert SA, Gontarek RR, Jackson JR, Kershner KL, Luo L, Raha K, Sherk CS, Sung C-M, Sutton D, Tummino PJ, Wegrzyn RJ, Auger KR, Dhanak D (2010) Discovery of GSK2126458, a highly potent inhibitor of PI3K and the mammalian target of rapamycin. ACS Med Chem Lett 1:39–43
Lee JY, Jeong KW, Shin S, Lee JU, Kim Y (2012) Discovery of novel selective inhibitors of Staphylococcus aureus beta-ketoacyl acyl carrier protein synthase III. Eur J Med Chem 47:261–269
Marone R, Cmiljanovic V, Giese B, Wymann MP (2008) Targeting phosphoinositide 3-kinase-moving towards therapy. Biochim Biophys Acta 1784:159–185
Marra DE, Simoncini T, Liao JK (2000) Inhibition of vascular smooth muscle cell proliferation by sodium salicylate mediated by upregulation of p21(Waf1) and p27(Kip1). Circulation 102:2124–2130
Pandeya S, Sriram D, Nath G, DeClercq E (1999) Synthesis, antibacterial, antifungal and anti-HIV activities of Schiff and Mannich bases derived from isatin derivatives and N-[4-(4′-chlorophenyl)thiazol-2-yl] thiosemicarbazide. Eur J Pharm Sci 9:25–31
Pomel V, Klicic J, Covini D, Church DD, Shaw JP, Roulin K, Burgat-Charvillon F, Valognes D, Camps M, Chabert C, Gillieron C, Francon B, Perrin D, Leroy D, Gretener D, Nichols A, Vitte PA, Carboni S, Rommel C, Schwarz MK, Ruckle T (2006) Furan-2-ylmethylene thiazolidinediones as novel, potent, and selective inhibitors of phosphoinositide 3-kinase gamma. J Med Chem 49:3857–3871
Rathelot P, Azas N, El-Kashef H, Delmas F, Di Giorgio C, Timon-David P, Maldonado J, Vanelle P (2002) 1,3-Diphenylpyrazoles: synthesis and antiparasitic activities of azomethine derivatives. Eur J Med Chem 37:671–679
Rommel C, Camps M, Ji H (2007) PI3Kδ and PI3Kγ: partners in crime in inflammation in rheumatoid arthritis and beyond. Nat Rev Immunol 7:191–201
Roy P, Kalra N, Prasad S, George J, Shukla Y (2009) Chemopreventive potential of resveratrol in mouse skin tumors through regulation of mitochondrial and PI3K/AKT signaling pathways. Pharm Res 26:211–217
Siddiqui HL, Iqbal A, Ahmad S, Weaver GW (2006) Synthesis and spectroscopic studies of new Schiff bases. Molecules 11:206–211
Smith JM, Nemeth TL, McDonald RA (2003) Current immunosuppressive agents: efficacy, side effects, and utilization. Pediatr Clin North Am 50:1283–1300
Suire S, Coadwell J, Ferguson GJ, Davidson K, Hawkins P, Stephens L (2005) p84, a new Gβγ-activated regulatory subunit of the type IB phosphoinositide 3-kinase p110γ. Curr Biol 15:566–570